Article Details

Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Retrieved on: 2023-10-21 21:32:19

Tags for this article:

Click the tags to see associated articles and topics

Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer. View article details on hiswai:

Excerpt

Disclosures: This research was supported by AstraZeneca. Some study authors declared affiliations with biotech, pharmaceutical, and/or device ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up